Mastek Q3 FY26 Earnings Call Transcript Released
Mastek Limited released its Q3 FY26 earnings call transcript on January 28, 2026. The call covered financial performance for the quarter ended December 31, 2025. Key financial highlights included a 60 basis points improvement in EBITDA margin to 16.1% despite revenue headwinds. The company added 17 new customers and declared an interim dividend of INR 8 per share.
The release of a conference call transcript provides detailed insights into the company's financial performance, strategic direction, and management's commentary on business challenges and opportunities. This information is material for investors and analysts, impacting their understanding and valuation of the company.
The announcement is a factual release of a conference call transcript. While the content discusses business performance and outlook, the release itself is a routine disclosure and does not inherently carry a positive or negative sentiment.
Mastek Limited has released the transcript of its Earnings Conference Call held on January 21, 2026, to discuss the financial performance for the quarter and nine months period ended December 31, 2025.
The call featured insights from Umang Nahata, CEO, and Deepak Kedia, CFO, along with investor relations representative Pratik Jagtap from E&Y LLP.
Key discussion points included the company's strengthening capabilities in digital engineering and AI, recognition by analyst firms, and continued focus on the Healthcare and Life Sciences sector. A significant development highlighted was winning a new large account in financial services, valued at approximately $20 million. The company also reported growth in its 12-month order backlog by 18.4% and total order backlog by over 30% year-over-year.
Despite facing headwinds such as seasonal furloughs and some project delays, which led to a 4.8% constant currency reduction in revenue, Mastek managed to improve its EBITDA margin by 60 basis points due to operational efficiencies and AI-led productivity gains. The company added 17 new customers in Q3 and maintained a strong cash position with INR 346 crores in net cash. An interim dividend of INR 8 per share was declared.
Discussions also touched upon strategic initiatives like shifting towards outcome-based contracts, balancing cost discipline with talent investment, and capital allocation for shareholder returns and AI-driven services. The company's approach to AI is focused on service execution rather than IP monetization.
The transcript provides detailed responses to investor queries regarding revenue decline, geographic performance, competition in the UK Public Sector, and the US market turnaround strategy. The company expects sustained growth from Q4 onwards.
What to do with a filing like this
Mastek Limited filed this with the NSE as a statutory disclosure, categorised under concall transcript released. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Mastek Limited. Read the original for the full detail.